KR20150011260A - 패치 및 화장료 조성물을 포함하는 미용 키트 및 미용 방법 - Google Patents
패치 및 화장료 조성물을 포함하는 미용 키트 및 미용 방법 Download PDFInfo
- Publication number
- KR20150011260A KR20150011260A KR20130086311A KR20130086311A KR20150011260A KR 20150011260 A KR20150011260 A KR 20150011260A KR 20130086311 A KR20130086311 A KR 20130086311A KR 20130086311 A KR20130086311 A KR 20130086311A KR 20150011260 A KR20150011260 A KR 20150011260A
- Authority
- KR
- South Korea
- Prior art keywords
- patch
- skin
- active ingredient
- cosmetic composition
- cosmetic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 239000002537 cosmetic Substances 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims description 27
- 230000003796 beauty Effects 0.000 title abstract 4
- 230000037303 wrinkles Effects 0.000 claims abstract description 40
- 239000004480 active ingredient Substances 0.000 claims abstract description 35
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 31
- 229930182490 saponin Natural products 0.000 claims abstract description 30
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 29
- 150000007949 saponins Chemical class 0.000 claims abstract description 29
- 108090000790 Enzymes Proteins 0.000 claims abstract description 28
- 102000004190 Enzymes Human genes 0.000 claims abstract description 28
- 239000012790 adhesive layer Substances 0.000 claims abstract description 17
- 238000010521 absorption reaction Methods 0.000 claims abstract description 10
- 239000010410 layer Substances 0.000 claims description 27
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 20
- 229920002674 hyaluronan Polymers 0.000 claims description 20
- 229960003160 hyaluronic acid Drugs 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 239000004615 ingredient Substances 0.000 claims description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 9
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 239000000416 hydrocolloid Substances 0.000 claims description 8
- 229920005862 polyol Polymers 0.000 claims description 8
- 150000003077 polyols Chemical class 0.000 claims description 8
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 5
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 5
- -1 polyethylene Polymers 0.000 claims description 5
- 229920003169 water-soluble polymer Polymers 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 229920006267 polyester film Polymers 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 229920006268 silicone film Polymers 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 2
- 238000004062 sedimentation Methods 0.000 claims 1
- 239000006071 cream Substances 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 25
- 230000000704 physical effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 44
- 235000017709 saponins Nutrition 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000006210 lotion Substances 0.000 description 17
- 238000009472 formulation Methods 0.000 description 15
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 13
- 230000000638 stimulation Effects 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 239000012676 herbal extract Substances 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 239000004005 microsphere Substances 0.000 description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 101710128038 Hyaluronan synthase Proteins 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- BGHNZAWRRWLKPO-UHFFFAOYSA-N Ginsenoside F1 Natural products CC(=C)CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C BGHNZAWRRWLKPO-UHFFFAOYSA-N 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000003522 acrylic cement Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 229920006272 aromatic hydrocarbon resin Polymers 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 229960005188 collagen Drugs 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- XNGXWSFSJIQMNC-FIYORUNESA-N ginsenoside F1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@H](O)[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XNGXWSFSJIQMNC-FIYORUNESA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000037384 skin absorption Effects 0.000 description 2
- 231100000274 skin absorption Toxicity 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229960000281 trometamol Drugs 0.000 description 2
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000028550 Auricularia auricula Species 0.000 description 1
- 235000000023 Auricularia auricula Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101150027313 Has2 gene Proteins 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 125000001124 arachidoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 229940049657 cyclomethicone 5 Drugs 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229920003049 isoprene rubber Polymers 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000013464 silicone adhesive Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000008491 skin homeostasis Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 229920001935 styrene-ethylene-butadiene-styrene Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
도 2는 가운데 부분을 차지하는 미세침 층(11)과 미세침 층을 둘러싸고 있는 점착층(12)을 포함하는 패치(10)의 이미지를 나타낸 것이다.
도 3은 미세침 층(11)과 점착층(12)을 포함하는 패치(10)의 측면도 이미지를 나타낸 것이다.
성 분 | 함량 (중량%) |
정제수 | 잔량 |
효소처리 홍삼 사포닌 | 0.1 |
히알루론산 | 30 |
트레할로오스(trehalose) | 25 |
카복시메틸셀로로오즈나트륨 | 25 |
글리세린 | 10 |
한방 추출물 | 적량 |
성 분 | 함량 (중량%) |
정제수 | 잔량 |
효소처리 홍삼 사포닌 | 0.1 |
히알루론산 | 20 |
트레할로오스 | 25 |
카복시메틸셀로로오즈나트륨 | 35 |
글리세린 | 10 |
한방 추출물 | 적량 |
성 분 | 함량 (중량%) |
정제수 | 잔량 |
효소처리 홍삼 사포닌 | 0.1 |
히알루론산 | 40 |
만니톨 | 20 |
카복시메틸셀로로오즈나트륨 | 20 |
부틸렌글리콜 | 10 |
한방 추출물 | 적량 |
성 분 | 함량 (중량%) |
정제수 | 잔량 |
효소처리 홍삼 사포닌 | 0.1 |
히알루론산 | 50 |
자일리톨 | 20 |
카복시메틸셀로로오즈나트륨 | 20 |
글리세린 | 10 |
한방 추출물 | 적량 |
성 분 | 함량 (중량%) |
정제수 | 잔량 |
효소처리 홍삼 사포닌 | 0.1 |
히알루론산 | 30 |
트레할로오스 | 25 |
카복시메틸셀로로오즈나트륨 | 25 |
글리세린 | 10 |
한방 추출물 | 적량 |
성 분 | 함량(중량%) |
이하 유상 파트 | |
스테아린산 | 0.5 |
세테아릴알코올 | 1.5 |
피토스쿠알란 | 7 |
사이클로메치콘 | 5 |
이하 수상 파트 | |
EDTA-2Na | 0.02 |
방부제, 향, 색소 | 적량 |
글리세린 | 5 |
트로메타민 | 0.05 |
소듐 폴리아크릴레이트 | 0.2 |
효소처리 홍삼사포닌 | 0.1 |
정제수 | 잔량 |
성 분 | 함량 (%) |
이하 유상 파트 | |
식물성 경화유 | 1.5 |
스테아린산 | 1 |
글리세릴 스테아레이트 | 1 |
세테아릴 알콜올 | 2 |
아라키딜/베헤닐 알코올&아라키딜 글루코사이드 | 1 |
세틸아릴 알코올 & 세테아릴 글루코사이드 | 2 |
액상파라핀 | 6 |
카프릴릭/카르릭 트리글리세라이드 | 6 |
이하 수상 파트 | |
EDTA-2Na | 0.02 |
방부제, 향, 색소 | 적량 |
글리세린 | 5 |
부틸렌 글리콜 | 5 |
카보머 | 0.05 |
트로메타민 | 0.05 |
효소처리 홍삼사포닌 | 0.1 |
정제수 | 잔량 |
팔자주름 평균 최고 깊이 편차 (um) |
감소율 (%) | |||
크림 사용군 | 22 | 0 | 321.73 ± 81.29 | - |
27 | 303.39 ± 89.52 | 5.70 | ||
패치 사용군 (9회 사용) | 22 | 0 | 337.48 ± 92.74 | - |
30 | 315.88 ± 72.39 | 6.40 | ||
크림과 패치 (9회 사용) 병용 사용군 | 22 | 0 | 323.36 ± 87.63 | - |
27 | 282.68 ± 85.37 | 12.58 |
실시예 | 패치의 부착 상태 | |||
부착 직후 | 30분 후 | 2시간 후 | 12시간 후 | |
실시예 1 | 우수 | 완벽하게 부착 | 부착상태 양호 | 부착상태 양호 |
실시예 2 | 우수 | 완벽하게 부착 | 부착상태 양호 | 부착상태 양호 |
실시예 3 | 우수 | 완벽하게 부착 | 부착상태 양호 | 부착상태 양호 |
비교예 1 | 낮음 | 30분 이전 탈락 | - | - |
사용 그룹 | 실시예 | 자극 정도 |
크림 사용 후 패치 적용 | 실시예 1 | 무자극 |
실시예 2 | 무자극 | |
실시예 3 | 무자극 | |
패치 단독 사용 | 실시예 1 | 무자극 |
실시예 2 | 경자극 | |
실시예 3 | 경자극 |
11: 미세침을 포함하는 미세침 층
12: 점착층
Claims (18)
- 유효성분을 포함하는 화장료 조성물; 및
상기 화장료 조성물을 도포한 부분에 사용되며, 유효성분의 흡수를 증진시키는 미세침을 포함하는 패치;
를 포함하는 미용 키트. - 제1항에 있어서,
상기 패치는 미세침을 포함하는 미세침 층과 상기 미세침 층을 둘러싸고 있는 점착층을 포함하는 것인, 미용 키트. - 제2항에 있어서,
상기 점착층은 점착제를 포함하며, 상기 점착제는 하이드로콜로이드 점착제인 것인, 미용 키트. - 제3항에 있어서,
상기 점착층은 지지체를 더 포함하며, 상기 지지체는 폴리에스테르 필름, 실리콘 필름, 폴리에틸렌 필름, 및 우레탄 필름으로 이루어진 군에서 선택된 하나 이상을 포함하는 것인, 미용 키트. - 제1항 내지 제4항 중 어느 한 항에 있어서,
상기 패치는 상기 화장료 조성물의 유효성분과 동일한 성분을 포함하는 것인, 미용 키트. - 제5항에 있어서,
상기 유효성분은 주름 개선 성분이고, 상기 패치는 주름 개선용인 것인, 미용 키트. - 제6항에 있어서,
상기 유효성분은 효소처리 홍삼 사포닌인, 미용 키트. - 제5항에 있어서,
상기 패치는 미세침을 1cm2 당 100~500개 포함하는 것인, 미용 키트. - 제5항에 있어서,
상기 미세침 층은 수용성 고분자를 포함하는 것인, 미용 키트. - 제9항에 있어서,
상기 수용성 고분자는 히알루론산 및 카복시메틸셀룰로오즈나트륨 중 하나 이상인, 미용 키트. - 제10항에 있어서,
상기 히알루론산의 함량은 전체 미세침을 구성하는 조성물 중에서 20~60 중량%인, 미용 키트. - 제5항에 있어서,
상기 패치의 미세침의 길이는 70-250um인 것인, 미용 키트. - 제9항에 있어서,
상기 미세침 층은 당 및 폴리올 중 하나 이상을 더 포함하는 것인, 미용 키트. - 제13항에 있어서,
상기 당의 함량은 전체 미세침을 구성하는 조성물 중에서 10~40 중량%이고, 상기 폴리올의 함량은 전체 미세침을 구성하는 조성물 중에서 1~20 중량%인, 미용 키트. - 제13항에 있어서,
상기 당은 만니톨, 트레할로스, 및 자일리톨로 이루어진 군에서 선택된 하나 이상인, 미용 키트. - 제13항에 있어서,
상기 폴리올은 글리세린, 부틸렌글리콜, 및 프로필렌글리콜로 이루어진 군에서 선택된 하나 이상인, 미용 키트. - 제5항에 따른 키트를 사용하는 미용 방법으로서, 상기 방법은
유효성분을 함유하는 화장품을 피부에 도포하는 단계; 및
화장품이 도포된 피부 부위에 미세침을 포함하는 패치를 부착하는 단계를 포함하는 미용 방법. - 제17항에 있어서,
상기 방법은 패치 부착 후 20분 이상의 시간이 경과한 후, 패치를 탈리하는 단계를 더 포함하는 미용 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130086311A KR20150011260A (ko) | 2013-07-22 | 2013-07-22 | 패치 및 화장료 조성물을 포함하는 미용 키트 및 미용 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130086311A KR20150011260A (ko) | 2013-07-22 | 2013-07-22 | 패치 및 화장료 조성물을 포함하는 미용 키트 및 미용 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20150011260A true KR20150011260A (ko) | 2015-01-30 |
Family
ID=52482684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR20130086311A KR20150011260A (ko) | 2013-07-22 | 2013-07-22 | 패치 및 화장료 조성물을 포함하는 미용 키트 및 미용 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20150011260A (ko) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160030793A (ko) * | 2014-09-11 | 2016-03-21 | 주식회사 엘지생활건강 | 흡수 속도를 개선한 마이크로니들 시스템 |
KR20160134446A (ko) * | 2015-05-13 | 2016-11-23 | 주식회사 엘지생활건강 | 피부 미백 효과가 있는 알부틴 전달용 용해성 미세바늘 패치 |
KR20160134444A (ko) * | 2015-05-13 | 2016-11-23 | 주식회사 엘지생활건강 | 비타민 e 또는 비타민 e 유도체 전달용 용해성 미세바늘 패치 |
KR20160145470A (ko) * | 2015-06-10 | 2016-12-20 | 주식회사 엘지생활건강 | 하이드로퀴논 전달용 용해성 미세바늘 패치 |
KR20170000747A (ko) * | 2015-06-24 | 2017-01-03 | 주식회사 엘지생활건강 | 트러블 개선 및 피부 재생을 위한 용해성 미세바늘 패치 |
KR20170000746A (ko) * | 2015-06-24 | 2017-01-03 | 주식회사 엘지생활건강 | 알파―리포산 전달용 용해성 미세바늘 패치 |
KR20180082177A (ko) * | 2017-01-10 | 2018-07-18 | 주식회사 아미코스메틱 | 사카로미세스 효모발효여과물, 아스파라거스줄기 추출물 및 관동꽃 추출물을 포함하는 화장료 조성물 |
KR200488960Y1 (ko) | 2018-12-28 | 2019-04-09 | 휴젤(주) | 이종 조성을 포함하는 휴대성이 우수한 일회용 포장 키트 |
US20220168193A1 (en) * | 2019-03-18 | 2022-06-02 | Labnpeople Co., Ltd. | Flexible metal patch having antioxidant activity and brightening effect and method for using same |
-
2013
- 2013-07-22 KR KR20130086311A patent/KR20150011260A/ko not_active IP Right Cessation
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160030793A (ko) * | 2014-09-11 | 2016-03-21 | 주식회사 엘지생활건강 | 흡수 속도를 개선한 마이크로니들 시스템 |
KR20160134446A (ko) * | 2015-05-13 | 2016-11-23 | 주식회사 엘지생활건강 | 피부 미백 효과가 있는 알부틴 전달용 용해성 미세바늘 패치 |
KR20160134444A (ko) * | 2015-05-13 | 2016-11-23 | 주식회사 엘지생활건강 | 비타민 e 또는 비타민 e 유도체 전달용 용해성 미세바늘 패치 |
KR20160145470A (ko) * | 2015-06-10 | 2016-12-20 | 주식회사 엘지생활건강 | 하이드로퀴논 전달용 용해성 미세바늘 패치 |
KR20170000747A (ko) * | 2015-06-24 | 2017-01-03 | 주식회사 엘지생활건강 | 트러블 개선 및 피부 재생을 위한 용해성 미세바늘 패치 |
KR20170000746A (ko) * | 2015-06-24 | 2017-01-03 | 주식회사 엘지생활건강 | 알파―리포산 전달용 용해성 미세바늘 패치 |
KR20180082177A (ko) * | 2017-01-10 | 2018-07-18 | 주식회사 아미코스메틱 | 사카로미세스 효모발효여과물, 아스파라거스줄기 추출물 및 관동꽃 추출물을 포함하는 화장료 조성물 |
KR200488960Y1 (ko) | 2018-12-28 | 2019-04-09 | 휴젤(주) | 이종 조성을 포함하는 휴대성이 우수한 일회용 포장 키트 |
US20220168193A1 (en) * | 2019-03-18 | 2022-06-02 | Labnpeople Co., Ltd. | Flexible metal patch having antioxidant activity and brightening effect and method for using same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20150011260A (ko) | 패치 및 화장료 조성물을 포함하는 미용 키트 및 미용 방법 | |
WO2020024703A1 (zh) | 一种水溶性富勒烯外用组合物 | |
TWI353861B (ko) | ||
TWI581809B (zh) | 用於刺激magp-1以改善皮膚外觀之組合物及方法 | |
CN106580797A (zh) | 一种美白祛斑霜及其制备方法 | |
AU2017345384A1 (en) | Extract of Anigozanthos flavidus for cosmetic use | |
WO2013187574A1 (ko) | 피부미백용 화장품 조성물 | |
CN105168038B (zh) | 金花葵花朵泥面膜及其制备方法 | |
KR102309958B1 (ko) | 구근추출물을 포함하는 피부 개선용 조성물 | |
US11285093B2 (en) | Cosmetic uses of swertiamarin | |
WO2014044808A2 (en) | Fast-penetration cosmetic dermal filler for topical application | |
KR101895038B1 (ko) | 스피큘을 포함하는 용해성 필름 및 이의 용도 | |
KR101895037B1 (ko) | 스피큘을 포함하는 하이드로겔 조성물 및 이의 용도 | |
KR102613845B1 (ko) | 천연물 유래의 피부개선용 화장조성물 | |
KR102227355B1 (ko) | 비자극성 약산성 각질제거 및 상피세포 영양 공급을 위한 복합 화장료 조성물 | |
KR20210053638A (ko) | 피부 상태 개선용 화장료 조성물 및 이의 제조방법 | |
CN100528127C (zh) | 一种活肤纳米乳状液化妆品及其制备方法 | |
KR20110057895A (ko) | 진세노사이드 Re 및 진세노사이드 화합물 K를 함유하는 히알루론산 생성 촉진용 피부 외용제 조성물 | |
KR100568601B1 (ko) | 진세노사이드 알지2를 함유하는 사포닌 혼합물로 이루어진피부보호용 화장료 조성물 | |
KR20150086922A (ko) | 천연발효 솔잎 추출물을 함유하는 피부자극의 완화 및 피부보습용 조성물 | |
KR20170079337A (ko) | 피부 온도 감응형 기능성 하이드로 겔을 이용한 얼굴윤곽 개선용 패치 및 그 제조방법 | |
CN103006530B (zh) | 一种具有防晒功效的蜂毒组合物 | |
KR20170001649A (ko) | 혼합 생약재 추출물을 함유하는 주름개선 및 보습용 조성물 | |
KR102372137B1 (ko) | 보습용 크림 조성물 및 이의 제조방법 | |
JP3522609B2 (ja) | ヒアルロン酸産生促進剤、及びこれを含有して成る皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20130722 |
|
PG1501 | Laying open of application | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20180706 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20130722 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190719 Patent event code: PE09021S01D |
|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20200226 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20190719 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
X091 | Application refused [patent] | ||
AMND | Amendment | ||
PX0901 | Re-examination |
Patent event code: PX09011S01I Patent event date: 20200226 Comment text: Decision to Refuse Application Patent event code: PX09012R01I Patent event date: 20191018 Comment text: Amendment to Specification, etc. |
|
PX0601 | Decision of rejection after re-examination |
Comment text: Decision to Refuse Application Patent event code: PX06014S01D Patent event date: 20200424 Comment text: Amendment to Specification, etc. Patent event code: PX06012R01I Patent event date: 20200325 Comment text: Decision to Refuse Application Patent event code: PX06011S01I Patent event date: 20200226 Comment text: Amendment to Specification, etc. Patent event code: PX06012R01I Patent event date: 20191018 Comment text: Notification of reason for refusal Patent event code: PX06013S01I Patent event date: 20190719 |
|
X601 | Decision of rejection after re-examination |